PlexusDx coordinates with your care team to ensure compounded semaglutide dosing accommodates these factors and includes safety checkpoints at regular intervals
Your habits determine the outcome
Semaglutide, like any medication, has side effects
Patients hold overwhelming demand for GLP-1s, but access (supply + list price cost) creates constraints Employers and payors are grappling with benefit design and coverage access qualifications for GLP-1s (e.g., limiting to diabetes patients)
[6] With Foundayo, Wegovy, and Zepbound all readily available in 2026, the prior shortage rationale for compounding has largely disappeared
Seeing a loved one navigate the process safely and successfully often makes the decision feel less daunting